This time last year, The Walt Disney Company’s [DIS] revenue was being driven by its theme parks and attractions, but with lockdowns and social distancing measures in place, some parks remain closed indefinitely. The ones that have reopened have seen limited attendance, meaning Disney’s share price has failed to impress since the pandemic began. As the company prepares to announce its fourth-quarter 2020 earnings on 12 November, the trends that have emerged since the pandemic began are continuing to have an impact on the bottom line, and could hit Disney’s share price further.
Although Disney’s share price through 9 November is up 80.3% from its 52-week low of $79.07, recorded on 18 March, it is still down 3.79% year-to-date. Disney’s share price is also down 7.05% from its 52-week high of $153.41, which it reached on 26 November last year following the launch of its Disney+ streaming service.
It would be fair to say that Disney’s share price has struggled in an economy suited to the rise of companies that rely on digital subscriptions and clicks to drive growth. Even the success of its streaming service has been unable to prevent revenue from falling in recent quarters.
The bare necessities
Disney’s share price rose following its Q3 2020 results at the beginning of August. This is despite the fact revenue for the three months to 27 June was down 42% from $20.26bn in Q3 2019 to $11.79bn, and its operating income plunged 72% year-over-year from $3.95bn to $1.09bn. The dip was due mainly to its Parks, Experiences and Products segment’s operating loss of $1.96bn.
More than half of the quarter’s revenue came from its Media Networks segment, which brought in $6.56bn, a year-over-year drop of 2%. This figure was bolstered by revenue from selling and licensing popular programmes, including The Simpsons and Modern Family, and lower costs as productions were forced to close down.
Disney's Q3 revenue - a 42% YoY drop
Circa a third of total revenue ($3.96bn) came from its direct-to-consumer and international segment, a year-over-year increase of 2%. This was thanks in part to the growing Disney+ subscriber base. As of the end of June, the streaming service had 57.5 million subscribers, with each one bringing in an average of $4.62 in revenue per month.
The Parks, Experiences and Products segment brought in $983m, an 85% year-over-year fall from $6.57bn. This represented a little over 8% of the total revenue, compared to 32% in Q3 2019.
No guidance was issued on the Q3 earnings call, but Disney did warn that its Products segment would see a fall in merchandise sales from Q4 2019 due to the pandemic-related lack of cinematic releases.
The resurgence of coronavirus cases, particularly in Florida where Disney’s main parks are located, was flagged as having an ongoing negative impact on its parks’ net contribution level.
According to Zacks data, 10 analysts are expecting the company to report revenue in the range of $12.65bn and $19.23bn. The consensus is $14.34bn, which would represent a 24.9% fall from Q4 2019. The same number of analysts are expecting earnings per share to be in the range of -$0.94 and -$0.06. The consensus of -$0.64 would be a steep 158% decline from the year-ago quarter and may well see Disney’s share price drop.
Disney's estimated Q4 revenue - a 24.9% YoY drop
In light of shifting streaming and media trends, Disney is expected to double down on its growing Disney+ venture, with more than 155 million projected subscribers worldwide by the end of 2024.
“Scaling [direct-to-consumer] in this land grab phase of the industry is key to success for Disney because it will drive significant opportunities to monetise a large subscriber base,” wrote Deutsche Bank’s Bryan Kraft in a note, upgrading the stock from Hold to Buy. He raised his price target from $128 to $163.
“Scaling [direct-to-consumer] in this land grab phase of the industry is key to success for Disney because it will drive significant opportunities to monetise a large subscriber base” - Bryan Kraft
Credit Suisse analyst Douglas Mitchelson cautioned in a note seen by Barron’s that Disney could add a large number of subscribers over the next five years or so, but it is not expected to capture market share from streaming rivals like Netflix [NFLX]. Mitchelson upgraded the stock from Neutral to Outperform, raising his price target from $116 to $146.
Given the headwinds, Disney’s share price could be overvalued, though.
Speaking to the BBC, Hargreaves Lansdown equity analyst Nicholas Hyett believes that while it may be “tempting to look to the new Disney+ business for good news,” the streaming service is not profitable yet and the company’s revenue is not likely to be raised off the floor in the near term.
|Operating Margin (TTM)||9.43%|
|Quarterly Revenue Growth (YoY)||-41.9%|
Disney share price vitals, Yahoo Finance, 10 November 2020
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.